WeVote
Log In

Bill

Bill

S 4772

Classifies 7 Hydroxymitragynine as Schedule I drug.

2024-2025 Regular Session Introduced by Shirley Turner

New Jersey bill would ban 7-Hydroxymitragynine (kratom's active compound) as Schedule I drug, restricting access to substance used by thousands for pain and withdrawal management.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
#drugabuse
0
WeVote Research Nonpartisan
Bill Summary · S 4772

Legislative bill overview

S 4772 would classify 7-Hydroxymitragynine (7-HMG), a primary alkaloid compound found in kratom, as a Schedule I controlled substance in New Jersey. This designation would make possession, distribution, and sale of the substance illegal under state law, placing it in the same category as drugs like heroin and LSD.

Why is this important

Kratom has gained significant popularity in the U.S. as a botanical supplement marketed for pain relief, anxiety, and opioid withdrawal management, with an estimated 3-5 million American users. Classifying its primary active compound as Schedule I would effectively prohibit kratom products in New Jersey and could influence other states' regulatory approaches, while potentially affecting consumers and the emerging kratom industry.

Potential points of contention

  • Scientific evidence debate: Limited FDA-approved research exists on 7-HMG's safety and efficacy; proponents argue insufficient evidence justifies Schedule I classification, while supporters cite concerns about addiction potential and lack of quality control
  • Consumer access vs. public health: Kratom users cite therapeutic benefits and prefer it to opioids, while regulators worry about dependence, contamination risks, and marketing claims lacking scientific support
  • Regulatory approach inconsistency: The DEA has not federally scheduled kratom despite previous consideration; state-level bans create fragmented policy and may conflict with ongoing research and harm-reduction philosophies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.